All Stories

  1. Role of Oral Glucagon‐Like Peptide‐1 Receptor Agonists in Weight Management for Individuals With Overweight or Obesity Without Diabetes: A Network Meta‐Analysis of Randomized Controlled Trials
  2. Safety and efficacy of glucagon like peptide-1 receptor agonism-based therapies in end-stage renal disease: A systematic review and meta-analysis
  3. Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis
  4. Efficacy and Safety of the Dual Glucagon‐Like Peptide‐1 and Glucagon Receptor Agonist Mazdutide in Predominantly Chinese Adults With Obesity and/or Type 2 Diabetes: A Systematic Review and Meta‐Analysis
  5. Comparative Efficacy and Safety of Tirzepatide in Asian and Non‐Asian Adults With Obesity Without Diabetes: A Systematic Review and Meta‐Analysis
  6. Diabetes distress: What a clinician needs to know – A South Asian perspective
  7. Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis
  8. Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs
  9. Efficacy of Initiation of Semaglutide versus SGLT2 inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Multicenter Propensity-Matched Real-World Study
  10. Early-Onset Type 2 Diabetes in Bangladesh: From Hidden Epidemic to Prevention Agenda
  11. Less Can Be More: Pragmatic Levothyroxine Use in the Elderly in the Era of Deprescribing
  12. From Induction to Maintenance? Rethinking GLP ‐1–Based Obesity Pharmacotherapy in the Era of Oral Agents
  13. Comparative Efficacy of GLP‐1 RAs Versus SGLT2 Inhibitors in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter Propensity Score‐Matched Real‐World Study
  14. Novel Amylin‐Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A Network Meta‐Analysis
  15. Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence
  16. Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Con...
  17. Upfront aspirin-free antiplatelet monotherapy after percutaneous coronary intervention: A systematic review and meta-analysis of safety and efficacy
  18. Redefining Osteoporosis: A Global Call for Equity, Evidence, and Access- Perspectives from Asia and Africa
  19. Exploring the Relationship Between Hypothyroidism and Metabolic Dysfunction-Associated Steatotic Liver Disease
  20. Efficacy and Safety of Upfront Oral Triple Lipid‐Lowering Therapy: A Systematic Review and Single‐Arm Meta‐Analysis
  21. Comparative Effectiveness of Liraglutide and Dulaglutide in Heart Failure with Preserved Ejection Fraction: A Propensity Score–Matched Real-World Study
  22. Safety and efficacy of somapacitan in adults with growth hormone deficiency who were switched from daily growth hormone therapy: A systematic review and meta-analysis
  23. Efficacy and Safety of Semaglutide for Managing Antipsychotic-associated Weight Gain: A Systematic Review and Meta-analysis
  24. Safety and efficacy of oral PCSK9 inhibitors in hypercholesterolemia: A systematic review and network meta-analysis
  25. Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies
  26. Impact of glucagon‐like peptide‐1 receptor agonism‐based therapies on limb outcomes in peripheral artery disease and type 2 diabetes: An updated systematic review and meta‐analysis
  27. Safety and efficacy of glucagon-like peptide-1 receptor agonists in individuals with type 2 diabetes mellitus fasting during Ramadan: a systematic review and meta-analysis
  28. Parental birth weight as a predictor of neonatal and childhood outcomes in children: a systematic review and meta-analysis
  29. Glycemic control, weight-loss effects, and safety of cotadutide in individuals with type 2 diabetes: A systematic review and meta-analysis
  30. Impact of semaglutide use on glycemic and metabolic profile in adults with type 1 diabetes having overweight or obesity: A systematic review and meta-analysis
  31. Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh
  32. Cardiovascular Outcomes in Adults With Type 2 Diabetes Treated With Tirzepatide: A Systematic Review and Meta-Analysis of Real-World Studies
  33. Impact of traumatic brain injury severity on anterior pituitary function: A prospective study
  34. Impact of sodium-glucose co-transporter-2 inhibitor combined with mineralocorticoid receptor antagonist therapy versus either agent alone in individuals with chronic kidney disease: A systematic review and meta-analysis
  35. A young girl presented with short stature with Sprengel deformity: A case report
  36. Berardinelli–Seip congenital lipodystrophy: A rare case report
  37. Trabecular Bone Score in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-Analysis
  38. Metformin use & asthma outcomes in patients with concurrent diabetes & bronchial asthma: A systematic review & meta-analysis
  39. Comparative Effectiveness of Glucagon-like Peptide-1- Receptor Agonists in Patients With Heart Failure With Preserved or Minimally Reduced Ejection Fraction: A Comprehensive Bayesian Network Meta-Analysis and Network Meta-Regression
  40. Efficacy and Safety of Once-Weekly IcoSema in Adults With Type 2 Diabetes: A Systematic Review and Meta-Analysis
  41. Safety of esaxerenone (CS-3150) and its impacts on blood pressure and renal function: A systematic review and meta-analysis
  42. Impacts of Ramadan Fasting on Metabolic and Hepatic Endpoints in Individuals With Metabolic Dysfunction‐Associated Fatty Liver Disease: A Systematic Review and Meta‐Analysis
  43. Comparison of FIB-4, APRI and AST/ALT ratio with FibroScan in patients with NAFLD and type 2 diabetes: a single-center study from Bangladesh
  44. Optimizing Bone Health in Diabetes: Strategies for Fracture Risk Reduction in Public Healthcare
  45. Thrice-Weekly Insulin Degludec Versus Once-Daily Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  46. Hypoglycaemia During Oral Glucose Tolerance Test in Pregnancy and Feto-Maternal Outcomes: A Systematic Review and Meta-Analysis
  47. One-hour vs Two-hour Postprandial Glucose Targets and Fetomaternal Outcomes in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
  48. Efficacy and Safety of Bexagliflozin, a Selective Sodium-Glucose Cotransporter-2 Inhibitor, in Type 2 Diabetes: A Systematic Review and Meta-Analysis
  49. Cardiovascular risk in newly diagnosed patients with type 2 diabetes mellitus: a nationwide, facility-based, cross-sectional study in Bangladesh
  50. Effect of beinaglutide, a thrice-daily GLP-1 receptor agonist, on body weight and metabolic parameters: A systematic review and meta-analysis
  51. Monogenic diabetes: An evidence-based clinical approach
  52. Neuropsychiatric Effects of Tirzepatide: A Systematic Review and Meta-Analysis
  53. Efficacy and Safety of Twincretin Survodutide, a Dual Glucagon-Like Peptide-1 and Glucagon Receptor Agonist as an Anti-Obesity and Anti-Diabetes Medication: A Systematic Review and Meta-Analysis
  54. Reasons for discontinuing tirzepatide in randomized controlled trials: A systematic review and meta-analysis
  55. Optimal Use of Once-Weekly Basal Insulin Efsitora Alfa in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis
  56. Metabolic outcomes of bariatric surgery versus lifestyle intervention in adolescents with severe obesity: A systematic review and meta‐analysis
  57. Impact of 1-Year Tirzepatide Use on Glycemic and Metabolic Profile in Overweight to Obese People with Type 1 Diabetes: A Systematic Review and Meta-Analysis
  58. Once-Weekly Tirzepatide Versus Once-Daily Basal Insulin in Managing Type 2 Diabetes Inadequately Controlled With Oral anti-Hyperglycemic Drugs: A Systematic Review and Meta-Analysis
  59. Tirzepatide and Cancer Risk in Individuals with and without Diabetes: A Systematic Review and Meta-Analysis
  60. Renal effects and safety of tirzepatide in subjects with and without diabetes: A systematic review and meta-analysis
  61. Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
  62. Association of SIRT1 rs3758391 Polymorphism With T2DM in Bangladeshi Population: Evidence From a Case‐Control Study and Meta‐Analysis
  63. Approach to Endocrine Hypertension: A Case-Based Discussion
  64. Efficacy and Safety of Glucagon Like Peptide-1 Receptor Agonism Based Therapies in Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis
  65. Efficacy and Safety of Early Initiation of Sodium–Glucose Co-transporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-analysis
  66. Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
  67. Treatment Versus Observation in Early Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  68. Efficacy and safety of the glucagon receptor antagonist volagidemab in type‐1 diabetes: A systematic review and meta‐analysis
  69. Pancreatic Safety of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta‐Analysis
  70. Efficacy and Safety of Novel Twincretin Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, as an Anti-obesity Medicine in Individuals Without Diabetes: A Systematic Review and Meta-analysis
  71. Role of Obeticholic Acid, a Farnesoid X Receptor Agonist, in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
  72. Hormone replacement therapy for menopausal mood swings and sleep quality: The current evidence
  73. Reply to the Letter to the Editor, Endocrine Practice for "Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis”
  74. Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies
  75. Hepatobiliary effects and safety of tirzepatide: A systematic review and meta‐analysis
  76. Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
  77. Demographic and Clinical Characteristics of Patients with Primary Hypothyroidism and Adequacy of Levothyroxine Replacement Therapy in Them: A Nationwide Study in Bangladesh
  78. Efficacy and Safety of Cagrilintide Alone and in Combination with Semaglutide (Cagrisema) as Anti-Obesity Medications: A Systematic Review and Meta-Analysis
  79. Serum Magnesium and Glycemic Status in Newly Diagnosed T2DM Patients in Tertiary Care Hospital of Bangladesh
  80. Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis
  81. Bariatric surgery and tirzepatide—Friends, not foes!
  82. Role of Resmetirom, a Liver-Directed, Thyroid Hormone Receptor Beta-Selective Agonist, in Managing Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
  83. Role of Growth Hormone Therapy in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
  84. Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis
  85. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis
  86. First-trimester fasting plasma glucose as a predictor of subsequent gestational diabetes mellitus and adverse fetomaternal outcomes: A systematic review and meta-analysis
  87. Role of Teplizumab, a Humanized Anti-CD3 Monoclonal Antibody, in Managing Newly Diagnosed Type 1 Diabetes: An Updated Systematic Review and Meta-Analysis
  88. Evaluation of Efficacy and Safety of Empagliflozin in Bangladeshi Patients with Type 2 Diabetes Mellitus (EFFISAEM Study)
  89. Metabolic association of serum prolactin in polycystic ovary syndrome: A retrospective analysis of 840 patients in Bangladesh
  90. Global Warming and Endocrinology: The Hyderabad Declaration of the South Asian Federation of Endocrine Societies
  91. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  92. Efficacy and Safety of Omarigliptin, a Novel Once-Weekly Dipeptidyl Peptidase-4 Inhibitor, in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
  93. Orforglipron, a novel non‐peptide oral daily glucagon‐like peptide‐1 receptor agonist as an anti‐obesity medicine: A systematic review and meta‐analysis
  94. Acute hypothermia in a patient with COVID-19: a case report and summary of the evidence
  95. Approach to management of hypo and hyperthyroidism in Bangladesh: a nationwide physicians’ perspective survey
  96. Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta‐Analysis
  97. Approach to a Patient with Discordant Thyroid Function
  98. Comparative Analysis of Metformin and Imeglimin: Exploring Therapeutic Implications
  99. Role of Chia Seed (Salvia hispanica L.) Supplements in Managing Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
  100. Safety and Efficacy of Semaglutide Use in Diabetes during Ramadan Fasting: A Real-world Experience from Bangladesh
  101. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study
  102. Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus – A countrywide study in Bangladesh
  103. Effect of Moringa oleifera Leaf Extract on Glycemic Parameters in Patients with Type 2 Diabetes Mellitus and Prediabetes: A Systematic Review and Meta-analysis
  104. Comparison of fasting and random lipid profiles among subjects with type 2 diabetes mellitus: an outpatient-based cross-sectional study in Bangladesh
  105. Fasting with diabetes during Ramadan: An updated review
  106. Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study
  107. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh
  108. Clinical and hormonal profile of polycystic ovary syndrome phenotypes: An observational study at a tertiary care hospital in Bangladesh
  109. Sexual dysfunction in women with type 2 diabetes mellitus: A single-centre cross-sectional study from Bangladesh
  110. Male infertility in diabetes mellitus: An insight into the pathophysiology
  111. Nonalcoholic fatty liver disease in polycystic ovary syndrome: Result of a single-center cross-sectional study in Bangladesh
  112. Thyroid disorders in bangladesh: An epidemiological perspective
  113. Bangladesh endocrine society guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum
  114. Comparison of Vitamin D Status between Resident and Nonresident Bangladeshis with Type 2 Diabetes Mellitus: A Single-Center, Cross-Sectional Study
  115. Coexistent papillary thyroid carcinoma in a patient with graves' disease
  116. Prevalence and characteristics of women with polycystic ovary syndrome in Bangladesh – A narrative review
  117. Hypocalcemic Seizures in Infancy and its Relationship with Maternal Vitamin D Deficiency
  118. Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus Fasting During Ramadan: A Real-World Study from Bangladesh
  119. Comparison of Serum Vitamin B12 Levels Among Drug-Naïve and Metformin-Treated Patients With Polycystic Ovary Syndrome
  120. Comparison of simplicity, convenience, safety, and cost-effectiveness between use of insulin pen devices and disposable plastic syringes by patients with type 2 diabetes mellitus: a cross-sectional study from Bangladesh
  121. Serum Zinc Level and Glycemic Status in Newly Diagnosed Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital of Bangladesh
  122. Comparison of Fasting and Random Lipid Profile among Subjects with Type-2 Diabetes Mellitus Patients: An Outpatient-Based Cross-Sectional Study in Bangladesh
  123. Prevalence and predictors of diabetes distress among adults with type 2 diabetes mellitus: a facility-based cross-sectional study of Bangladesh
  124. A 27-year-old man with rare genetic disorder presented with morbid obesity
  125. Advanced polyostotic fibrous dysplasia
  126. Subtype and severity of stroke at presentation in subjects with and without type 2 diabetes
  127. Precocious puberty: diagnosis and management
  128. Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease
  129. Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
  130. Comparison of clinical, metabolic, and hormonal parameters in lean vs. obese women with polycystic ovary syndrome: a single-center study from Bangladesh
  131. Correlation of serum amylase level with the severity of acute organophosphorus compounds poisoning
  132. Serum thyroglobulin level in newly detected thyrotoxicosis and its role in differential diagnosis of thyrotoxicosis
  133. Neck circumference as a predictor of obesity and metabolic syndrome in bangladeshi women with polycystic ovary syndrome
  134. Demographic, Clinical and Biochemical Characteristics of Drug Naive Type 2 Diabetes Patients of Bangladesh
  135. Serum vitamin B12 status of patients with type 2 diabetes mellitus on metformin: A single-center cross-sectional study from Bangladesh
  136. Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus–related compensated chronic liver disease
  137. Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome
  138. Evaluation of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as markers of diabetic kidney disease in Bangladeshi patients with type 2 diabetes mellitus
  139. Management of Diabetes in Pregnancy During COVID-19 Pandemic
  140. Comparison of risk factors, management and outcome between early and lately detected gestational diabetes mellitus patients
  141. Serum uric acid level in Bangladeshi adults with essential hypertension
  142. Frequency and correlates of comorbid depression in polycystic ovary syndrome
  143. Insulin Injection Practice and Injection Complications – Results from the Bangladesh Insulin Injection Technique Survey
  144. Vitamin D status of overweight and obese Bangladeshi adults
  145. Prevalence of thyroid dysfunction and thyroid autoimmunity in polycystic ovary syndrome: A multicenter study from Bangladesh
  146. Comparison of the nonfasting and fasting lipid profiles of the patients admitted in the cardiology department of a tertiary hospital in Bangladesh
  147. Impact of Subclinical Hypothyroidism on Reproductive and Metabolic Parameters in Polycystic Ovary Syndrome – A Cross-sectional Study from Bangladesh
  148. Predisposing factors of hypoglycemia in patients with type 2 diabetes mellitus presented with symptomatic hypoglycemia in a tertiary hospital of Bangladesh
  149. Divergences in Clinical, Anthropometric, Metabolic, and Hormonal Parameters among Different Phenotypes of Polycystic Ovary Syndrome Presenting at Endocrinology Outpatient Departments: A Multicenter Study from Bangladesh
  150. Knowledge and Practice of Physicians to Hyperglycemia in Pregnancy: A Nationwide Survey in Bangladesh
  151. Serum c-peptide level in newly diagnosed Bangladeshi adults with type 2 diabetes mellitus
  152. Circadian variation in stroke: a hospital-based study
  153. Seroprevalence of Hepatitis B and Hepatitis C in end-stage renal disease patients on maintenance hemodialysis: a single-center study from Bangladesh
  154. Frequency and predictors of hyperglycemia in patients with various thyroid disorders attending a tertiary hospital of Bangladesh
  155. Serum magnesium status and its correlation with insulin resistance in newly diagnosed patients with type 2 diabetes mellitus
  156. Vitamin D Status in Primary Hypothyroid Subjects Attending a Specialized Endocrine Center of Bangladesh
  157. Short-Term Weight Changes in Treated Primary Hypothyroid Subjects
  158. Iodine nutrition status in Graves' disease: A single-center study from Bangladesh
  159. Effect of Intravenous Methylprednisolone on the Signs & Symptoms of Graves’ Ophthalmopathy
  160. Thyroid function and autoantibody status in Bangladeshi patients with type 2 diabetes mellitus
  161. Impact of iodine nutrition status on thyroid autoimmunity in subclinical hypothyroid patients attending a tertiary hospital of Bangladesh
  162. Serum Ferritin in Newly Detected Diabetes and Prediabetes
  163. Vitamin B12 is Found Sufficient in Newly Diagnosed Type 2 Diabetes in a Hospital Based Study